A new CoEHAR systematic review and meta-analysis, published in Internal and Emergency Medicine, has examined the available evidence on the relationship between electronic cigarette use and metabolic health outcomes, including
Smoking remains one of the most important — and most neglected — modifiable risk factors in the management of type 2 diabetes (T2D). Despite strong evidence that quitting reduces cardiovascular
For people living with diabetes, smoking represents much more than a harmful habit — it is a major driver of cardiovascular complications and long-term metabolic damage. Quitting is one of
For two days, on November 10 and 11, Catania became the world capital of research on diabetes and smoking. At the Plaza Hotel, the first Delphi Consensus Meeting of the
On November 10 and 11, 2025, Catania will become a key meeting point for the international scientific community with the International Diabetology Collegium, dedicated to the application of the Delphi method
On November 10–11, 2025, Catania will be at the center of the international scientific debate on the link between smoking and type 2 diabetes. Through the application of the Delphi
On May 30–31, 2025, the international scientific conference “TYPE 2 Diabetes in Internal Medicine Practice: Experience Sharings 1” was held in Catania, at the Romano Palace Hotel, bringing together over
The University of Catania is proud to announce the upcoming international scientific conference titled “TYPE 2 Diabetes in Internal Medicine Practice: Experience Sharings 1”, which will take place on May 30-31, 2025,
On Saturday 16th November, Prof. Riccardo Polosa joined the 2024 Annual Cardiorenal, Obesity & Metabolic Health Summit held in Fujairah (UAE) to deliver an oral presentation on diabetes, smoking cessation
New Partnerships for the International Research Project Diasmoke Thanks to additional funding from the PNRR Heal Italia, the first national supply chain dedicated to research and innovation in Precision Medicine,
